ProQR (PRQR) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
ProQR Therapeutics N.V. has reported a decrease in total assets from €137,883 thousand at the end of 2023 to €118,051 thousand by June 30, 2024, while equity attributable to owners decreased from €41,390 thousand to €32,854 thousand in the same period. The company’s financial performance shows a loss for the six-month period ending June 30, 2024, with a total comprehensive income of negative €10,074 thousand compared to negative €17,044 thousand in the previous year. These financial results reflect the ongoing costs and challenges faced by the company in its operations.
For further insights into PRQR stock, check out TipRanks’ Stock Analysis page.